Results 221 to 230 of about 7,544,041 (411)

Vision Transformers with Autoencoders and Explainable AI for Cancer Patient Risk Stratification Using Whole Slide Imaging [PDF]

arXiv
Cancer remains one of the leading causes of mortality worldwide, necessitating accurate diagnosis and prognosis. Whole Slide Imaging (WSI) has become an integral part of clinical workflows with advancements in digital pathology. While various studies have utilized WSIs, their extracted features may not fully capture the most relevant pathological ...
arxiv  

Myocardial revascularization with coronary endarterectomy. Stratification of risk factors for early mortality [PDF]

, 2000
Fernando Antibas Atik, Luís Alberto Oliveira Dallan, Sérgio Almeida de Oliveira, Luiz Augusto Ferreira Lisboa, Fernando Platania, Richard Haltí Cabral, Adib Jatene   +6 more
openalex   +1 more source

Placebo Effect Sizes in Clinical Trials of Knee Osteoarthritis Using Intra‐Articular Injections of Biologic Agents

Arthritis Care &Research, EarlyView.
Objective Patients with knee osteoarthritis rely on symptomatic treatments, in which up to 75% of the pain reduction can be attributed to the placebo effect. This effect may vary based on treatment type (eg, biologics vs nonbiologic injection) and route of administration (eg, intra‐articular vs topical vs oral).
Johanna M. Borst, Severin Ruoss, Ian Palmer, Trevor Smith, Kenneth Kalunian, Samuel R. Ward   +5 more
wiley   +1 more source

Interchangeability of carotid and femoral intima-media thickness in risk stratification? [PDF]

, 2000
E. Rietzschel, M. De Buyzere, T. De Backer, Daniel Duprez, D Clément   +4 more
openalex   +1 more source

Risk of Hepatotoxicity in Patients With Gout Treated With Febuxostat or Benzbromarone: A Propensity Score–Matched Cohort Study

Arthritis Care &Research, EarlyView.
Objective The objective of this study was to evaluate and compare the risk of hepatotoxicity associated with the use of febuxostat and benzbromarone in patients with gout. Methods New users of febuxostat or benzbromarone with monitoring of liver function at least three times in a year after initiation of the study drugs were identified from an ...
Wenyan Sun, Lingling Cui, Robert Terkeltaub, Ying Chen, Xinde Li, Xiaoyu Cheng, Tian Liu, Nicola Dalbeth, Changgui Li   +8 more
wiley   +1 more source

CaseCohortCoxSurvival: an R Package for Case-Cohort Inference for Relative Hazard and Pure Risk under the Cox Model [PDF]

arXiv
The case-cohort design allows analysis of multiple endpoints and only requires covariates to be measured for cases and non-cases in a random subcohort from the cohort. Stratification of subcohort sampling and weight calibration increase efficiency of estimates of log-relative hazards and covariate-specific pure risk, but they may require specifically ...
arxiv  

Malignant hyperthermia susceptibility: anaesthetic implications and risk stratification

, 1997
R. B. Abraham, Alex Cahana, R Krivosic-Horber, Azriel Perel   +3 more
openalex   +1 more source

Coronary disease: Acute coronary syndromes: risk stratification [PDF]

, 2000
Adam Timmis
openalex   +1 more source

Moderators and mediators of pain and function outcomes in a new service delivery model for management of knee osteoarthritis in primary care (PARTNER): Secondary exploratory analysis of a randomized controlled trial

Arthritis Care &Research, Accepted Article.
Objective Explore moderators and mediators influenced changes in pain and function in people with knee osteoarthritis (OA) receiving a new model of primary care service delivery (PARTNER), at 12 months (ACTRN12617001595303). Methods Secondary analyses of a cluster randomized controlled trial comparing PARTNER to usual general practitioner‐delivered ...
Abdolhay Farivar, Jocelyn L Bowden, Kim L Bennell, Andrew M Briggs, Stephen J Bunker, Rana S Hinman, Thorlene Egerton, Simon D French, Marie Pirotta, Karen Schuck, Venkatesha Venkatesha, Nicholas A Zwar, David J Hunter   +12 more
wiley   +1 more source

Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases

Hepatology, 2017
G. Garcia‐Tsao, J. Abraldes, A. Berzigotti, J. Bosch   +3 more
semanticscholar   +1 more source